Investment
Features
FeesSafety
Academy
More
Pluang+

New crypto Pepeto raises $11.23M amid Ethereum's bullish $10,000 price forecast for 2026.

Market News
16 Oct 2026
Unknown
View Source
Bullish
New crypto Pepeto raises $11.23M amid Ethereum's bullish $10,000 price forecast for 2026.

Pepeto, a new cryptocurrency on the Ethereum network, has quickly raised over $11.23 million in its presale, with each funding stage closing faster than the last. This momentum comes as Ethereum is predicted to reach $10,000 by the end of 2026, driven by strong demand and limited supply. Pepeto combines meme coin appeal with a full trading ecosystem, setting it apart from typical meme tokens and attracting significant investor interest. The project's rapid capital raise and innovative features position it as a promising opportunity for early investors looking to capitalize on Ethereum's growth.

The new cryptocurrency Pepeto and Ethereum price predictions provide context for market conditions. For readers following US stocks on Pluang, here is the market snapshot as of Oct 16, 2026 23:41 WIB: out of 150 priced stocks, 62 rose and 86 fell. BlackBerry Limited (BB) traded at USD 8.21 with a 1-day change of -5.63%, Hewlett Packard Enterprise Co (HPE) was at USD 55.53 with a -5.28% change, and Opendoor Technologies Inc (OPEN) stood at USD 2.20 with a -5.17% change.

More News

BlackRock's stake in Fagron drops below 3% after share transfers, holding 2.96% voting rights as of October 2026.

BlackRock's stake in Fagron drops below 3% after share transfers, holding 2.96% voting rights as of October 2026.

BlackRock, Inc. disclosed that its voting rights in pharmaceutical company Fagron NV fell below the 3% reporting threshold due to the transfer of voting securities, despite acquiring financial instruments equivalent to voting rights. As of October 12...

Market News
Neutral
1 hour ago
FDA approves phentolamine eye drops for presbyopia, offering a new treatment for age-related near vision loss.

FDA approves phentolamine eye drops for presbyopia, offering a new treatment for age-related near vision loss.

Opus Genetics announced FDA approval of phentolamine ophthalmic solution 0.75% for treating presbyopia, an age-related condition affecting near vision in adults. This approval, based on successful Phase 3 trials, provides a non-invasive option that i...

Market News
Bullish
1 hour ago
K2 Vision performs 5,000 Light Adjustable Lens procedures, leading globally in this advanced vision tech.

K2 Vision performs 5,000 Light Adjustable Lens procedures, leading globally in this advanced vision tech.

K2 Vision has completed over 5,000 procedures using the Light Adjustable Lens (LAL), making it the highest-volume practice worldwide for this technology. The LAL is unique because it can be adjusted after implantation to fine-tune vision based on the...

Market News
Bullish
1 hour ago
BlackRock's stake in Fagron falls below 3% after share disposals, now holding 2.96% voting rights.

BlackRock's stake in Fagron falls below 3% after share disposals, now holding 2.96% voting rights.

BlackRock, Inc. disclosed that its shareholding in Fagron NV dropped below the 3% threshold to 2.96% after selling some voting securities, despite acquiring equivalent financial instruments. As of October 12, 2026, BlackRock holds 2,015,779 voting ri...

Market News
Neutral
1 hour ago
Meridian International Center names 25 leaders shaping U.S. global influence across sectors in 2026 cohort

Meridian International Center names 25 leaders shaping U.S. global influence across sectors in 2026 cohort

Meridian International Center announced its inaugural New Architects of American Influence cohort, recognizing 25 leaders from business, technology, culture, sports, and government who are shaping U.S. global influence. The 2026 cohort includes leade...

Market News
Bullish
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App